EGFR and neoplasm: Through this analysis, the researchers validated the impact of AuNPs (0.45 mmol) on EGFR downstream signaling pathways over time, and found that AuNPs gradually diminish EGFR activation, which results in inactivation of downstream players leads to tumor suppression.